A device can be ready for patients but still lack a security owner or face critical medical device security risks. My starting point: give every connected device a named owner, confirm its support status, and rank security findings by possible patient harm - not technical scores alone.
I focus on five steps from purchase through retirement:
- Know what’s connected: Track devices, software, support dates, and the systems they depend on.
- Assign responsibility: Define hospital, manufacturer, and service provider duties - and who can accept remaining risk.
- Verify fixes: Check updates, settings, alarms, and care workflows before closing a finding.
- Limit exposure: Restrict network traffic and vendor access while planning patches or replacement.
- Protect care: Prepare backup equipment and downtime procedures before disconnecting devices.
The test I use is simple: <u>Can we show that the device is safer without making care less safe?</u> That takes verified controls, documented decisions, and regular reviews - not just closed tickets.
The Biggest Medical Device Cybersecurity Misconceptions Explained | Ep 86
sbb-itb-535baee
Link Device Vulnerabilities to Patient-Care Risk
After deployment, assess device security findings by clinical impact - not technical score alone. Set remediation priorities based on device function, patient dependence, network reachability, and acceptable downtime. Device-specific examples show why these differences matter.
Infusion Pumps: Medication Delivery and Settings
A compromised pump can directly affect medication delivery.
An unauthorized user could alter pump settings and change medication dosage. A connectivity loss could block dosage data from the EMR and delay treatment.[1]
Assess settings changes and connectivity loss separately. Each can affect care in a different way.
Patient Monitors and Diagnostic Equipment: Readings and Availability
Apply the same approach to monitoring and diagnostic devices.
A vulnerability could suppress vital-sign readings at the bedside or central station. A ransomware attack could cut off diagnostic equipment and patient records, leaving staff without access during care.[1]
Score bedside readings, central displays, and alarms separately. The clinical effects of the same vulnerability can change depending on how staff use the device.
Prioritize Findings by Clinical Impact
Similar technical findings can pose very different risks to patients. Rank findings by potential patient harm, then assign those clinical priorities to the right owners.
Assign Provider, Manufacturer, and Service Provider Duties
After ranking a finding by patient impact, assign the work and identify who can sign off. Task ownership, remediation, and residual-risk acceptance are separate duties. Owning a task does not give someone authority to accept residual risk. Keeping those duties separate turns a finding into a remediation plan with clear accountability.
Set Internal Roles and Decision Authority
Hospital leadership should approve the device risk strategy and name who can accept residual risk. Clinical engineering should keep device data current in the CMMS and IoMT tools, then validate that data during preventive and corrective maintenance.
IT and security should review devices during procurement, assess MDS2 and SBOM information, assign cybersecurity risk ratings during commissioning, and monitor patch availability. Clinical leaders should assess the effects on workflows and patient safety. Document these handoffs in shared SOPs rather than relying on informal agreements.
Document Manufacturer and Service Provider Duties
Put cybersecurity expectations in purchasing and service agreements. Cover vulnerability disclosure, validated patches or software changes, support requirements, and end-of-life notices. Require MDS2 and SBOM in procurement documents.
Service providers should use approved access, perform authorized maintenance and updates, and document completed work. Their service and maintenance work should follow hospital SOPs for access and updates.
Map Responsibilities and Required Evidence
Use a responsibility matrix to spell out each handoff. The assignments below offer a starting point; approval authority should follow hospital policy.
| Role | Primary responsibility | Key deliverables/evidence |
|---|---|---|
| Hospital leadership | Risk strategy and acceptance authority | Formal risk strategy, procurement approval, documented risk acceptance |
| Clinical engineering | Device function and maintenance | CMMS registration, hardening, preventive maintenance validation |
| IT security | Exposure and risk assessment | MDS2/SBOM review, cybersecurity risk ratings, patch monitoring |
| Clinical leaders | Workflow and safety impact | Downtime procedures, clinical impact assessment |
| Manufacturers | Vulnerability disclosure and validated updates | Validated patches, SBOM, end-of-life notices |
| Service providers | Authorized access, maintenance, and updates | Access logs, maintenance records, update documentation |
If remediation stalls, document interim controls and explain why the device remains in use until remediation is complete or the designated approver formally accepts the risk.
Build a Repeatable Device Risk Process
Medical Device Security: A Closed-Loop Risk Process
Once roles are defined, put them to work in a repeatable device-risk process.
Use one closed-loop workflow: discover → assess → assign → remediate → verify → reassess. Keep one record per device or device group that includes its clinical function, owner, due date, decisions, evidence, and next review date. Continue reassessment throughout the device’s life - not just until the first finding closes.[2]
Inventory Devices and Map Dependencies
Record each device’s manufacturer, model, serial number, location, function, owner, network connection, software version, support status, maintenance contact, and retirement date. Reconcile purchasing and maintenance records with passive network discovery. Coordinate discovery with clinical engineering, and use active scanning only after clinical engineering and the manufacturer confirm it is safe.
Map each device’s gateways, servers, cloud services, interfaces, authentication systems, vendor connections, and downstream vendors. Document the data moving between them, who owns each dependency, and how a failure would affect care. This keeps the device’s technical state tied to its clinical impact. Assess the connected system, not just the bedside hardware.
Use that inventory as the reference for every vulnerability notice and remediation decision.
Track Findings and Verify Resolution
Match vulnerability intelligence and manufacturer notices to inventory records, then weigh exposure against patient-care impact. Track each finding’s owner, due date, patch-test plan, interim controls, and replacement path.
A completed ticket isn’t proof of resolution. Close findings only after verifying software versions, settings, alarms, interfaces, and affected workflows.
Review high-risk devices monthly and the full inventory quarterly. Review again after moves, updates, and changes in clinical use. Give every temporary risk acceptance an expiration date and a reassessment trigger.
Centralize Risk Records in Censinet RiskOps™
Keep findings, evidence, and review dates in a central record so teams don’t lose track of them. Use Censinet RiskOps™ to centralize assessments, ownership, remediation, and evidence. Link findings to manufacturer documentation, internal decisions, test results, and verification records so teams can trace the decision history.
Reduce Exposure Now and Plan Lasting Fixes
Once device risk is tracked in one place, reduce exposure with network controls, vendor access limits, and response plans.
Every connected clinical device needs a current exposure-control plan. Include known vulnerabilities, compensating controls, monitoring, a patch or upgrade path, a replacement deadline, and incident-response contacts.
Limit Network Exposure and Vendor Access
Use segmentation or micro-segmentation to permit only required clinical and management traffic, including traffic between device groups. Before enforcing rules, confirm required connections with clinical engineering and affected departments. These include medication-library updates, central monitoring, alarms, and other required dependencies. Block unnecessary internet access without disrupting services the device needs.
Apply the same rules to vendor access, which often creates the broadest remote path into a device. Treat vendor access as a clinical risk path, not just an IT convenience. Require a named technician, an approved maintenance window, MFA, least privilege, session logging, and automatic expiration. Afterward, the device owner reviews the maintenance record and logs.
Plan Patching, Replacement, and Incident Response
Work with clinical engineering and care departments to coordinate manufacturer-validated updates, testing, downtime, and rollback. If patches aren't available, use hardening, monitoring, physical safeguards, or protective gateways. These controls limit exposure; they don't remove the vulnerability.
Set replacement triggers for lost support, network isolation that makes care unsafe, or unreliable device operation. Assign a procurement owner and target date. When technical containment isn't enough, move to clinical continuity planning rather than isolating devices on the fly.
Coordinate device isolation with the care team unless immediate harm requires emergency action. Isolation can interrupt monitoring, dosing, or diagnostics. Prepare backup equipment, alternate monitoring or medication-delivery workflows, patient-transfer criteria, and restoration tests. Network disconnection is not a safe clinical shutdown.
Conclusion: Measure Device Risk Accountability
Track inventory completeness, ownership coverage, overdue high-risk findings, and unsupported devices with approved replacement plans. Measure progress by verified protection and safe care - not closed tickets alone. Give temporary controls an expiration date and document the residual-risk decision.
Use the following measures to connect immediate protection with a named owner, proof of completion, and the next step.
| Risk condition | Immediate protection | Accountable owner | Evidence of completion | Long-term resolution |
|---|---|---|---|---|
| Unsupported device on a broad network | Segment, restrict traffic, and monitor | Clinical engineering and IT security | Validated controls and risk acceptance | Replace or upgrade by target date |
| Critical vulnerability awaiting a patch | Restrict network and vendor access; monitor exploitation | Device owner and security operations | Control validation and alert review | Apply and verify manufacturer patch |
| Always-on vendor access | Require time-limited MFA sessions | Vendor-management owner and IT security | Approved session log and maintenance review | Revise support architecture and contract terms |
| Suspected compromise or unsafe device behavior | Activate incident response and care-continuity procedures | Incident commander and clinical leader | Clinical handoff and recovery validation | Remediate root cause and review lessons learned |
FAQs
How do we assess patient harm when a device vulnerability has no known exploits?
Focus on clinical function and potential impact, not just whether an exploit is possible in theory. Start with a device inventory that records each asset’s clinical role, location, and critical workflows.
Use threat modeling frameworks such as STRIDE to identify failure modes, including denial of service or unauthorized data modification. Document what happens when devices fail or someone tampers with their outputs. Prioritize ventilators and infusion pumps, since malfunctions in these devices directly threaten patient safety.
What if a manufacturer won’t validate a security patch?
Document formal risk acceptance, including the technical reasons the device can’t be patched and the risk that remains. Reduce exposure with compensating controls, such as network segmentation, access restrictions, application whitelisting, or added monitoring.
Record these decisions in your central risk register and set a review date - typically every 90 to 180 days. Obtain official approval from senior leadership or a cross-functional risk committee.
How do we test device segmentation without disrupting care?
Use passive network discovery to map how devices communicate and support clinical workflows. Group devices by function, risk, and criticality. Then test segmentation policies with simulated clinical scenarios to find and fix connectivity issues.
Roll out changes in phases, starting with lower-criticality systems or pilot areas. IT security and clinical engineering should jointly review changes for their impact on patient care. Review policies periodically and test downtime procedures annually.
